Cargando…

Expiratory flow limitation in intensive care: prevalence and risk factors

BACKGROUND: Expiratory flow limitation (EFL) is characterised by a markedly reduced expiratory flow insensitive to the expiratory driving pressure. The presence of EFL can influence the respiratory and cardiovascular function and damage the small airways; its occurrence has been demonstrated in diff...

Descripción completa

Detalles Bibliográficos
Autores principales: Volta, Carlo Alberto, Dalla Corte, Francesca, Ragazzi, Riccardo, Marangoni, Elisabetta, Fogagnolo, Alberto, Scaramuzzo, Gaetano, Grieco, Domenico Luca, Alvisi, Valentina, Rizzuto, Chiara, Spadaro, Savino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896682/
https://www.ncbi.nlm.nih.gov/pubmed/31806045
http://dx.doi.org/10.1186/s13054-019-2682-4
_version_ 1783476834279620608
author Volta, Carlo Alberto
Dalla Corte, Francesca
Ragazzi, Riccardo
Marangoni, Elisabetta
Fogagnolo, Alberto
Scaramuzzo, Gaetano
Grieco, Domenico Luca
Alvisi, Valentina
Rizzuto, Chiara
Spadaro, Savino
author_facet Volta, Carlo Alberto
Dalla Corte, Francesca
Ragazzi, Riccardo
Marangoni, Elisabetta
Fogagnolo, Alberto
Scaramuzzo, Gaetano
Grieco, Domenico Luca
Alvisi, Valentina
Rizzuto, Chiara
Spadaro, Savino
author_sort Volta, Carlo Alberto
collection PubMed
description BACKGROUND: Expiratory flow limitation (EFL) is characterised by a markedly reduced expiratory flow insensitive to the expiratory driving pressure. The presence of EFL can influence the respiratory and cardiovascular function and damage the small airways; its occurrence has been demonstrated in different diseases, such as COPD, asthma, obesity, cardiac failure, ARDS, and cystic fibrosis. Our aim was to evaluate the prevalence of EFL in patients requiring mechanical ventilation for acute respiratory failure and to determine the main clinical characteristics, the risk factors and clinical outcome associated with the presence of EFL. METHODS: Patients admitted to the intensive care unit (ICU) with an expected length of mechanical ventilation of 72 h were enrolled in this prospective, observational study. Patients were evaluated, within 24 h from ICU admission and for at least 72 h, in terms of respiratory mechanics, presence of EFL through the PEEP test, daily fluid balance and followed for outcome measurements. RESULTS: Among the 121 patients enrolled, 37 (31%) exhibited EFL upon admission. Flow-limited patients had higher BMI, history of pulmonary or heart disease, worse respiratory dyspnoea score, higher intrinsic positive end-expiratory pressure, flow and additional resistance. Over the course of the initial 72 h of mechanical ventilation, additional 21 patients (17%) developed EFL. New onset EFL was associated with a more positive cumulative fluid balance at day 3 (103.3 ml/kg) compared to that of patients without EFL (65.8 ml/kg). Flow-limited patients had longer duration of mechanical ventilation, longer ICU length of stay and higher in-ICU mortality. CONCLUSIONS: EFL is common among ICU patients and correlates with adverse outcomes. The major determinant for developing EFL in patients during the first 3 days of their ICU stay is a positive fluid balance. Further studies are needed to assess if a restrictive fluid therapy might be associated with a lower incidence of EFL.
format Online
Article
Text
id pubmed-6896682
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-68966822019-12-11 Expiratory flow limitation in intensive care: prevalence and risk factors Volta, Carlo Alberto Dalla Corte, Francesca Ragazzi, Riccardo Marangoni, Elisabetta Fogagnolo, Alberto Scaramuzzo, Gaetano Grieco, Domenico Luca Alvisi, Valentina Rizzuto, Chiara Spadaro, Savino Crit Care Research BACKGROUND: Expiratory flow limitation (EFL) is characterised by a markedly reduced expiratory flow insensitive to the expiratory driving pressure. The presence of EFL can influence the respiratory and cardiovascular function and damage the small airways; its occurrence has been demonstrated in different diseases, such as COPD, asthma, obesity, cardiac failure, ARDS, and cystic fibrosis. Our aim was to evaluate the prevalence of EFL in patients requiring mechanical ventilation for acute respiratory failure and to determine the main clinical characteristics, the risk factors and clinical outcome associated with the presence of EFL. METHODS: Patients admitted to the intensive care unit (ICU) with an expected length of mechanical ventilation of 72 h were enrolled in this prospective, observational study. Patients were evaluated, within 24 h from ICU admission and for at least 72 h, in terms of respiratory mechanics, presence of EFL through the PEEP test, daily fluid balance and followed for outcome measurements. RESULTS: Among the 121 patients enrolled, 37 (31%) exhibited EFL upon admission. Flow-limited patients had higher BMI, history of pulmonary or heart disease, worse respiratory dyspnoea score, higher intrinsic positive end-expiratory pressure, flow and additional resistance. Over the course of the initial 72 h of mechanical ventilation, additional 21 patients (17%) developed EFL. New onset EFL was associated with a more positive cumulative fluid balance at day 3 (103.3 ml/kg) compared to that of patients without EFL (65.8 ml/kg). Flow-limited patients had longer duration of mechanical ventilation, longer ICU length of stay and higher in-ICU mortality. CONCLUSIONS: EFL is common among ICU patients and correlates with adverse outcomes. The major determinant for developing EFL in patients during the first 3 days of their ICU stay is a positive fluid balance. Further studies are needed to assess if a restrictive fluid therapy might be associated with a lower incidence of EFL. BioMed Central 2019-12-05 /pmc/articles/PMC6896682/ /pubmed/31806045 http://dx.doi.org/10.1186/s13054-019-2682-4 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Volta, Carlo Alberto
Dalla Corte, Francesca
Ragazzi, Riccardo
Marangoni, Elisabetta
Fogagnolo, Alberto
Scaramuzzo, Gaetano
Grieco, Domenico Luca
Alvisi, Valentina
Rizzuto, Chiara
Spadaro, Savino
Expiratory flow limitation in intensive care: prevalence and risk factors
title Expiratory flow limitation in intensive care: prevalence and risk factors
title_full Expiratory flow limitation in intensive care: prevalence and risk factors
title_fullStr Expiratory flow limitation in intensive care: prevalence and risk factors
title_full_unstemmed Expiratory flow limitation in intensive care: prevalence and risk factors
title_short Expiratory flow limitation in intensive care: prevalence and risk factors
title_sort expiratory flow limitation in intensive care: prevalence and risk factors
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896682/
https://www.ncbi.nlm.nih.gov/pubmed/31806045
http://dx.doi.org/10.1186/s13054-019-2682-4
work_keys_str_mv AT voltacarloalberto expiratoryflowlimitationinintensivecareprevalenceandriskfactors
AT dallacortefrancesca expiratoryflowlimitationinintensivecareprevalenceandriskfactors
AT ragazziriccardo expiratoryflowlimitationinintensivecareprevalenceandriskfactors
AT marangonielisabetta expiratoryflowlimitationinintensivecareprevalenceandriskfactors
AT fogagnoloalberto expiratoryflowlimitationinintensivecareprevalenceandriskfactors
AT scaramuzzogaetano expiratoryflowlimitationinintensivecareprevalenceandriskfactors
AT griecodomenicoluca expiratoryflowlimitationinintensivecareprevalenceandriskfactors
AT alvisivalentina expiratoryflowlimitationinintensivecareprevalenceandriskfactors
AT rizzutochiara expiratoryflowlimitationinintensivecareprevalenceandriskfactors
AT spadarosavino expiratoryflowlimitationinintensivecareprevalenceandriskfactors